PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Aqueous and methanol leaf extracts improved inflammation, pain, and histological features in CFA-induced mono-arthritis in rats [PMID:30849505].
Extracts demonstrated therapeutic effects in monosodium urate-induced gout in rats by reducing inflammation and hyperalgesia [PMID:41991677].
Ethanolic leaf extract reduced stool load of S. flexneri in Wistar rats [PMID:31969010].
Ethyl acetate extract and its isolated triterpenoid showed considerable activity against drug-resistant Candida strains and clinical isolates in vitro [PMID:42224217].
Extracts showed significant cytotoxicity and antitumor activity in breast, lung, cervical, and liver cancer cell lines and in EAC tumor-bearing mice [PMID:36873464].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 42224217 (2026) — Potent and broad-spectrum anti-Candida activity of 6α-(3'-methoxy-4'-hydroxybenzoyl)-lup-20(29)-ene-3-one, a triterpenoid from Paullinia pinnata. · PloS one
- 2.PMID: 41991677 (2026) — Aqueous and methanol extracts of Paullinia pinnata improve MSUc uptake in macrophages and in vitro antioxidant effects. · Scientific reports
- 3.PMID: 13873207 (1962) — Cardiotonic action of two tannins. · British journal of pharmacology and chemotherapy
- 4.PMID: 30849505 (2019) — Aqueous and methanol extracts of Paullinia pinnata L. (Sapindaceae) improve inflammation, pain and histological features in CFA-induced mono-arthritis: Evidence from in vivo and in vitro studies. · Journal of ethnopharmacology
- 5.PMID: 36873464